Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,657 | 88,525 | 105,481 | 104,923 | 97,654 |
| Marketable Securities | 128,795 | 172,005 | 189,902 | 216,137 | 233,172 |
| Receivables | 91,325 | 91,177 | 93,394 | 79,069 | 72,456 |
| Inventories | 5,232 | 5,044 | 6,873 | 8,087 | 7,562 |
| Other current assets | 29,173 | 29,170 | 0 | 0 | 0 |
| TOTAL | $355,684 | $398,462 | $409,977 | $421,968 | $427,125 |
| Non-Current Assets | |||||
| PPE Net | 8,396 | 8,457 | 7,593 | 7,777 | 7,421 |
| Investments And Advances | 39,669 | 10,101 | 20,548 | 20,323 | 19,426 |
| Other Non-Current Assets | 42,675 | 40,168 | 41,929 | 40,352 | 37,282 |
| TOTAL | $90,740 | $58,726 | $70,070 | $68,452 | $64,129 |
| Total Assets | $446,424 | $457,188 | $480,047 | $490,420 | $491,254 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 37,686 | 35,741 | 34,305 | 32,676 | 33,000 |
| Accounts payable and accrued liabilities | 5,567 | 8,589 | 10,049 | 11,644 | 13,482 |
| Accrued Expenses | 118,778 | 107,114 | 92,635 | 113,292 | 104,197 |
| Other current liabilities | 26,423 | 23,708 | N/A | N/A | N/A |
| TOTAL | $190,237 | $177,160 | $139,855 | $160,384 | $153,567 |
| Non-Current Liabilities | |||||
| Long Term Debt | 633,473 | 690,636 | 782,026 | 795,922 | 796,108 |
| Other Non-Current Liabilities | 8,861 | 8,943 | 7,779 | 7,924 | 8,065 |
| TOTAL | $644,076 | $701,622 | $792,119 | $805,970 | $806,250 |
| Total Liabilities | $834,313 | $878,782 | $931,974 | $966,354 | $959,817 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 210,543 | 209,920 | 209,250 | 208,960 | 207,133 |
| Common Shares | 2,105 | 2,099 | 2,092 | 2,085 | 2,071 |
| Retained earnings | -1,752,024 | -1,764,923 | -1,770,008 | -1,770,040 | -1,743,245 |
| Other shareholders' equity | 1,140 | 1,646 | 1,132 | 921 | 2,293 |
| TOTAL | $-387,889 | $-421,594 | $-451,927 | $-475,934 | $-468,563 |
| Total Liabilities And Equity | $446,424 | $457,188 | $480,047 | $490,420 | $491,254 |